Table of Contents

company-logo

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-like kinase inhibitor program, which is in Phase 1/2 clinical trial for the treatment of advanced leukemias and solid tumors. Its development programs also comprise Sapacitabine, a novel nucleoside analog that is orally available prodrug of CNDAC, which is in Phase 1/2 clinical trials to treat acute myeloid leukemia and myelodysplastic syndrome; and seliciclib, a CDK inhibitor that is in Phase 2 investigator-sponsored trials (IST) for Cushing's disease, as well as in Phase 1/2 IST for the treatment for advanced rheumatoid arthritis. The company has a clinical collaboration agreement with the University of Texas MD Anderson Cancer Center to clinically evaluate the safety and efficacy of three cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemias, acute myeloid leukemias, myelodysplastic syndromes, and other advanced leukemias. Cyclacel Pharmaceuticals, Inc. is headquartered in Berkeley Heights, New Jersey.

Cyclacel Pharmaceuticals Dividend Announcement

• Cyclacel Pharmaceuticals announced a annually dividend of $0.00 per ordinary share which will be made payable on 2016-08-01. Ex dividend date: 2016-07-13
• Cyclacel Pharmaceuticals's trailing twelve-month (TTM) dividend yield is -%
• Cyclacel Pharmaceuticals's payout ratio for the trailing twelve months (TTM) is -0.57%

Cyclacel Pharmaceuticals Dividend History

Ex-Div dateDividend amountDividend typePay date
2016-07-13$0.00annually2016-08-01

Cyclacel Pharmaceuticals Dividend per year

Cyclacel Pharmaceuticals Dividend Yield

Cyclacel Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Cyclacel Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Cyclacel Pharmaceuticals Financial Ratios

P/E ratio-0.05
PEG ratio-0.01
P/B ratio0.81
ROE-1873.74%
Payout ratio-0.57%
Current ratio1.07
Quick ratio1.07
Cash Ratio0.83

Cyclacel Pharmaceuticals Dividend FAQ

Does Cyclacel Pharmaceuticals stock pay dividends?
Cyclacel Pharmaceuticals does not currently pay dividends to its shareholders.
Has Cyclacel Pharmaceuticals ever paid a dividend?
No, Cyclacel Pharmaceuticals has no a history of paying dividends to its shareholders. Cyclacel Pharmaceuticals is not known for its dividend payments.
Why doesn't Cyclacel Pharmaceuticals pay dividends?
There are several potential reasons why Cyclacel Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Cyclacel Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Cyclacel Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Cyclacel Pharmaceuticals a dividend aristocrat?
Cyclacel Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Cyclacel Pharmaceuticals a dividend king?
Cyclacel Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Cyclacel Pharmaceuticals a dividend stock?
No, Cyclacel Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Cyclacel Pharmaceuticals stocks?
To buy Cyclacel Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Cyclacel Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.